HSA
STIM icon

Hussman Strategic Advisors’s Neuronetics STIM Stock Holding History

Hussman Strategic Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-310,000
Closed -$902K – 338
2023
Q1 		$902K Buy
+310,000
New +$1.56M 0.14% 226
2021
Q4 		– Sell
-37,200
Closed -$244K – 343
2021
Q3 		$244K Hold
37,200
– – 0.05% 285
2021
Q2 		$596K Buy
+37,200
New +$514K 0.12% 245

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Hussman Strategic Advisors's STIM Position: Q2 2023 in Review

Hussman Strategic Advisors sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 310,000 shares — an estimated $902K sold.

Hussman Strategic Advisors first reported a position in STIM in Q2 2021 and held it in 3 quarters. The position peaked at $902K in Q1 2023. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

  • Hussman Strategic Advisors reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 310,000 Neuronetics shares in Q2 2023, an estimated $902K.
  • Hussman Strategic Advisors first reported a position in Neuronetics in Q2 2021 and held it in 3 quarters.
  • Hussman Strategic Advisors's Neuronetics position peaked at $902K in Q1 2023.
  • 69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on Hussman Strategic Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.